Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07117799) titled 'A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Healthy Adults' on Aug. 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Basic Science. Masking: None (Open Label).

Primary Sponsor: Pfizer

Condition: Healthy Adults

Intervention: Drug: PF-07248144 Drug: PF-07248144

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: February 4, 2025

Target Sample Size: 24

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/ct2/sh...